Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Medical Research and Opinion

• Publication date

  2011-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/03007995.2011.598144PMID 21728907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resolution of statin-induced myalgias by correcting vitamin D deficiency.

  2011cited by this paper
• Update in vitamin D.

  2010cited by this paper
• Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study.

  2010cited by this paper
• Resolution of Statin-Induced Myalgias by Correcting Vitamin D Deficiency

  2010cited by this paper
• The genetics of statin-induced myopathy.

  2010cited by this paper
• Vitamin D deficiency in adults: when to test and how to treat.

  2010cited by this paper
• Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004

  2009cited by this paper
• Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients.

  2009influential reference
• Increased Levels of 25 Hydroxyvitamin D and 1,25-Dihydroxyvitamin D After Rosuvastatin Treatment: A Novel Pleiotropic Effect of Statins?

  2009cited by this paper
• Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?

  2009cited by this paper
• Simvastatin Does Not Affect Vitamin D Status, but Low Vitamin D Levels Are Associated with Dyslipidemia: Results from a Randomised, Controlled Trial

  2009cited by this paper
• Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.

  2009cited by this paper
• Vitamin D insufficiency – a novel mechanism of statin‐induced myalgia?

  2009cited by this paper
• How do you treat patients with myalgia who take statins?

  2009cited by this paper
• The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

  2009cited by this paper
• Hypovitaminosis D in African Americans Residing in Memphis, Tennessee With and Without Heart Failure

  2008cited by this paper
• Vitamin D deficiency: a worldwide problem with health consequences.

  2008cited by this paper
• Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men.

  2008cited by this paper
• Prevalence & potential significance of vitamin D deficiency in Asian Indians.

  2008cited by this paper
• Abstract 3701: Vitamin D Deficiency is Associated With Myalgias in Hyperlipidemic Subjects Taking Statins

  2008cited by this paper
• Low vitamin D status in a representative sample of youth from Québec, Canada.

  2008cited by this paper
• SLCO1B1 variants and statin-induced myopathy--a genomewide study.

  2008cited by this paper
• Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.

  2007cited by this paper
• Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease.

  2007cited by this paper
• Vitamin d and rehabilitation: improving functional outcomes.

  2007cited by this paper
• Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.

  2007cited by this paper
• Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects.

  2006cited by this paper
• Vitamin D physiology.

  2006cited by this paper
• Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia

  2006cited by this paper
• Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.

  2006cited by this paper
• Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients

  2006cited by this paper
• High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors

  2006cited by this paper
• Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography--tandem mass spectrometry.

  2005cited by this paper
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

  2004cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y.

  2004cited by this paper
• Is there value in liver function test and creatine phosphokinase monitoring with statin use?

  2004cited by this paper
• Statin-associated myopathy.

  2003cited by this paper
• Vitamin D in preventive medicine: are we ignoring the evidence?

  2003cited by this paper
• Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.

  2002cited by this paper
• Vitamin D and Muscle Function

  2002cited by this paper
• Statin‐associated myopathy

  2001cited by this paper
• Hypovitaminosis D in a sunny country.

  1999cited by this paper

• Effects of Vitamin D, Infliximab, and Leflunomide on Isolated Rat Striated Muscle with Electrical and Mechanical Stimuli in Statin-Induced Rhabdomyopathy

  2025cites this paper
• Statins, Vitamin D, and Cardiovascular Health: A Comprehensive Review

  2025cites this paper
• No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial.

  2023cites this paper
• Statin Intolerance: a Review and Update.

  2023cites this paper
• Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice

  2023cites this paper
• ¿Podría la Vitamina D ser una aliada en la Lucha contra el Dolor Crónico? ¿Qué dice la evidencia?

  2023cites this paper
• Association Between Vitamin D Supplementation and Statin-Associated Muscle Symptoms: A Systematic Review

  2022influential citation
• NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.

  2022cites this paper
• Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo.

  2022cites this paper
• Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels

  2022cites this paper
• Biomarkers of statin-induced musculoskeletal pain: Vitamin D and beyond

  2022cites this paper
• Vitamin D as therapeutic modulator in cerebrovascular diseases: a mechanistic perspectives

  2022cites this paper
• Metabolic Myopathies

  2022cites this paper
• Effects of vitamin D level and oxidant-antioxidant balance on postoperative morbidity in diabetic and non-diabetic patients undergoing off-pump bypass surgery

  2022cites this paper
• Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar.

  2021cites this paper
• A Literature Review of the Potential Impact of Medication on Vitamin D Status

  2021cites this paper
• Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis

  2021cites this paper
• RMHP_A_316897 3357..3381

  2021cites this paper
• Statin-Associated Muscle Symptoms Are Real

  2020cites this paper
• Risk Factors for SAMS

  2020cites this paper
• Common drugs as micronutrient disruptors: A selection for clinical practice

  2020cites this paper
• A Review of the Role Micronutrient Status in the Elderly Plays in Their Immune Response to Viral Respiratory Infections and the Potential Compromising Effects Medications Might Cause

  2020cites this paper
• The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations

  2020cites this paper
• Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update

  2018cites this paper
• Important drug-micronutrient interactions: A selection for clinical practice

  2018cites this paper
• Vitamin D in der Schmerztherapie

  2018cites this paper
• Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases

  2018cites this paper
• Magnesium Supplementation in Vitamin D Deficiency

  2017cites this paper
• Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort

  2017cites this paper
• Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients

  2017cites this paper
• Low serum vitamin D, statin associated muscle symptoms, vitamin D supplementation.

  2017cites this paper
• Significant association b etween statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients

  2017cites this paper
• Vitamin D in Pain Management

  2017cites this paper
• Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study

  2017cites this paper
• PCSK9 Inhibitors Show Value for Patients and the US Health Care System.

  2017cites this paper
• Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment

  2017cites this paper
• Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study

  2017cites this paper
• Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy

  2017cites this paper
• Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge

  2017cites this paper
• Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

  2016cites this paper
• Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center

  2016cites this paper
• Impact of vitamin D status on statin-induced myopathy

  2016cites this paper
• Safety of 50,000-100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance

  2016cites this paper
• Statin myopathy: over-rated and under-treated?

  2016cites this paper
• Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review.

  2016influential citation
• Low Vitamin D Levels and Genetic Polymorphism in the Vitamin D Receptor are Associated with Increased Risk of Statin‐Induced Myopathy

  2016cites this paper
• Safe use of statins: focus on muscle toxicity

  2016cites this paper
• ¿Existe relación entre los niveles séricos de vitamina D (25OHD) y el dolor musculoesquelético relacionado con la ingesta de estatinas? Revisión sistemática

  2016influential citation
• Is Vitamin D Deficiency a Risk Factor for the Development of Statin-Induced Myalgia in Patients Receiving Statins ?

  2016cites this paper
• Vitamin D deficiency and its role in neurological conditions: A review.

  2016cites this paper
• Impact of Vitamin D Status on Statin-Induced Myopathy 1

  2016cites this paper
• Treatment Options for Statin-Associated Muscle Symptoms.

  2015cites this paper
• Statin intolerance

  2015cites this paper
• ASSOCIATION OF VITAMIN D WITH STATIN INDUCED MYALGIA

  2015cites this paper
• Statin Intolerance and Vitamin D Supplementation

  2015cites this paper
• Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D Supplementation

  2015influential citation
• Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study.

  2015cites this paper
• Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.

  2014cites this paper
• Overcoming toxicity and side-effects of lipid-lowering therapies.

  2014cites this paper
• Vitamin D and stroke: promise for prevention and better outcome.

  2014cites this paper
• Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?

  2014cites this paper
• Dietary modulators of statin efficacy in cardiovascular disease and cognition.

  2014cites this paper
• Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes

  2014cites this paper
• Statin-associated myopathy: from genetic predisposition to clinical management.

  2014cites this paper
• Severe Vitamin D Deficiency, Myopathy, and Rhabdomyolysis

  2013cites this paper
• The roles of vitamin D in skeletal muscle: form, function, and metabolism.

  2013cites this paper
• A Clinical Review of Statin-Associated Myopathy

  2013cites this paper
• NEWS FROM THE AAN ANNUAL MEETING: A Proper Diagnosis of Psychogenic Nonepileptic Seizure Prompts Fewer Clinic Visits, Study Finds

  2013cites this paper
• [Vitamin D: skeletal and muscular effects].

  2013cites this paper
• Praktisches Vorgehen bei Hyperlipidämien

  2013cites this paper
• Does low serum 25 OH vitamin D interact with very strenuous physical activity, facilitating development of rhabdomyolysis?

  2013cites this paper
• Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.

  2013influential citation
• Discontinuation of statin therapy due to muscular side effects: a survey in real life.

  2013cites this paper
• Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

  2013cites this paper
• Effects of widely used drugs on micronutrients: a story rarely told.

  2013cites this paper
• Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D

  2012cites this paper
• Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.

  2012cites this paper
• Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins

  2012cites this paper
• Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.

  2012cites this paper
• Original article Daily and intermittent rosuvastatin 5mg therapy in statin intolerant patients: an observational study

  2012cites this paper
• Statin induced myotoxicity.

  2012cites this paper
• Safety of statins: an update

  2012cites this paper
• Therapeutic options for statin-intolerant patients

  2012cites this paper
• Influence of drugs on vitamin D and calcium metabolism

  2012cites this paper
• Integration of Transcriptomic and Metabolomic Profiling to Identify Mechanisms and Biomarkers of Statin-Induced Myopathy

  2012cites this paper
• Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study

  2012cites this paper
• Vitamin D Deficiency: Subclinical and Clinical Consequences on Musculoskeletal Health

  2012cites this paper
• Vitamin D deficiency, statin-related myopathy and other links with vascular risk

  2011influential citation
• ORIGINAL ARTICLES

  2006cites this paper